Key facts
- This page summarizes Frederic Pla's Form 4 filing for Akoya Biosciences, Inc. (AKYA).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 27 Mar 2023, 20:07.
Frederic Pla - 23 Mar 2023 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)
- Reporting relationship
- Chief Operating Officer
- Issuer ticker
- AKYA
- Reported as of
- 23 Mar 2023
- Net transaction value
- -$14,957
- SEC form
- 4
- Accepted by SEC
- 27 Mar 2023, 20:07:51 UTC
- Prior SEC filing
- 27 Feb 2023
- Next SEC filing
- 11 Sep 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Frederic Pla, by Brian McKelligon, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Frederic Pla filed Form 4 for Akoya Biosciences, Inc. (AKYA) on 27 Mar 2023.
Change
- Previous filing in this sequence was filed on 27 Feb 2023.
- Current net transaction value: -$14,957.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AKYA
transaction
Common Stock
Tax liability
- Transaction value
- $14,957
- Shares
- -1,945
- Change %
- -4.6%
- Price
- $7.69
- Shares after
- 40,555
- Date
- 23 Mar 2023
- Ownership
- Direct
* marks a reported price that did not pass the local price check.